Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Therapeutic Radioisotopes Industry Research Report 2021 Segmented by Major Market Players, Types, Applications and Countries Forecast to 2027

  • HNY4518856
  • 143 Pages
  • June 2021
  • Pharmaceuticals
Download Sample    Get Discount   
 
The global Therapeutic Radioisotopes market is expected to reach US$ XX Million by 2027, with a CAGR of XX% from 2020 to 2027, based on HNY Research newly published report.

The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).

By Market Verdors:

Bayer

Novartis

China Isotope & Radiation

Dongcheng

Q BioMed

Curium Pharmaceuticals

Jubilant DraxImage

Lantheus

Spectrum Pharmaceuticals

Progenics Pharmaceuticals

International Isotopes

By Types:

Radium-223

Lutetium-177

Iodine-131

Other

By Applications:

Thyroid

Bone Metastasis

Lymphoma

Other

Key Indicators Analysed

Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.

Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.

Market Trends: Market key trends which include Increased Competition and Continuous Innovations.

Opportunities and Drivers: Identifying the Growing Demands and New Technology

Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Key Reasons to Purchase

To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.

Assess the production processes, major issues, and solutions to mitigate the development risk.

To understand the most affecting driving and restraining forces in the market and its impact in the global market.

Learn about the market strategies that are being adopted by leading respective organizations.

To understand the future outlook and prospects for the market.

Besides the standard structure reports, we also provide custom research according to specific requirements.

1 Report Overview

1.1 Study Scope and Definition

1.2 Research Methodology

1.2.1 Methodology/Research Approach

1.2.2 Data Source

1.3 Key Market Segments

1.4 Players Covered: Ranking by Therapeutic Radioisotopes Revenue

1.5 Market Analysis by Type

1.5.1 Global Therapeutic Radioisotopes Market Size Growth Rate by Type: 2021 VS 2027

1.5.2 Radium-223

1.5.3 Lutetium-177

1.5.4 Iodine-131

1.5.5 Other

1.6 Market by Application

1.6.1 Global Therapeutic Radioisotopes Market Share by Application: 2022-2027

1.6.2 Thyroid

1.6.3 Bone Metastasis

1.6.4 Lymphoma

1.6.5 Other

1.7 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth

1.7.1 Covid-19 Impact: Global GDP Growth, 2019, 2021 and 2022 Projections

1.7.2 Covid-19 Impact: Commodity Prices Indices

1.7.3 Covid-19 Impact: Global Major Government Policy

1.8 Study Objectives

1.9 Years Considered

2 Global Therapeutic Radioisotopes Market Trends and Growth Strategy

2.1 Market Top Trends

2.2 Market Drivers

2.3 Market Challenges

2.4 Porter’s Five Forces Analysis

2.5 Market Growth Strategy

2.6 SWOT Analysis

3 Global Therapeutic Radioisotopes Market Players Profiles

3.1 Bayer

3.1.1 Bayer Company Profile

3.1.2 Bayer Therapeutic Radioisotopes Product Specification

3.1.3 Bayer Therapeutic Radioisotopes Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.2 Novartis

3.2.1 Novartis Company Profile

3.2.2 Novartis Therapeutic Radioisotopes Product Specification

3.2.3 Novartis Therapeutic Radioisotopes Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.3 China Isotope & Radiation

3.3.1 China Isotope & Radiation Company Profile

3.3.2 China Isotope & Radiation Therapeutic Radioisotopes Product Specification

3.3.3 China Isotope & Radiation Therapeutic Radioisotopes Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.4 Dongcheng

3.4.1 Dongcheng Company Profile

3.4.2 Dongcheng Therapeutic Radioisotopes Product Specification

3.4.3 Dongcheng Therapeutic Radioisotopes Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.5 Q BioMed

3.5.1 Q BioMed Company Profile

3.5.2 Q BioMed Therapeutic Radioisotopes Product Specification

3.5.3 Q BioMed Therapeutic Radioisotopes Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.6 Curium Pharmaceuticals

3.6.1 Curium Pharmaceuticals Company Profile

3.6.2 Curium Pharmaceuticals Therapeutic Radioisotopes Product Specification

3.6.3 Curium Pharmaceuticals Therapeutic Radioisotopes Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.7 Jubilant DraxImage

3.7.1 Jubilant DraxImage Company Profile

3.7.2 Jubilant DraxImage Therapeutic Radioisotopes Product Specification

3.7.3 Jubilant DraxImage Therapeutic Radioisotopes Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.8 Lantheus

3.8.1 Lantheus Company Profile

3.8.2 Lantheus Therapeutic Radioisotopes Product Specification

3.8.3 Lantheus Therapeutic Radioisotopes Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.9 Spectrum Pharmaceuticals

3.9.1 Spectrum Pharmaceuticals Company Profile

3.9.2 Spectrum Pharmaceuticals Therapeutic Radioisotopes Product Specification

3.9.3 Spectrum Pharmaceuticals Therapeutic Radioisotopes Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.10 Progenics Pharmaceuticals

3.10.1 Progenics Pharmaceuticals Company Profile

3.10.2 Progenics Pharmaceuticals Therapeutic Radioisotopes Product Specification

3.10.3 Progenics Pharmaceuticals Therapeutic Radioisotopes Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.11 International Isotopes

3.11.1 International Isotopes Company Profile

3.11.2 International Isotopes Therapeutic Radioisotopes Product Specification

3.11.3 International Isotopes Therapeutic Radioisotopes Production Capacity, Revenue, Price and Gross Margin (2016-2021)

4 Global Therapeutic Radioisotopes Market Competition by Market Players

4.1 Global Therapeutic Radioisotopes Production Capacity Market Share by Market Players (2016-2021)

4.2 Global Therapeutic Radioisotopes Revenue Market Share by Market Players (2016-2021)

4.3 Global Therapeutic Radioisotopes Average Price by Market Players (2016-2021)

5 Global Therapeutic Radioisotopes Production by Regions (2016-2021)

5.1 North America

5.1.1 North America Therapeutic Radioisotopes Market Size (2016-2021)

5.1.2 Therapeutic Radioisotopes Key Players in North America (2016-2021)

5.1.3 North America Therapeutic Radioisotopes Market Size by Type (2016-2021)

5.1.4 North America Therapeutic Radioisotopes Market Size by Application (2016-2021)

5.2 East Asia

5.2.1 East Asia Therapeutic Radioisotopes Market Size (2016-2021)

5.2.2 Therapeutic Radioisotopes Key Players in East Asia (2016-2021)

5.2.3 East Asia Therapeutic Radioisotopes Market Size by Type (2016-2021)

5.2.4 East Asia Therapeutic Radioisotopes Market Size by Application (2016-2021)

5.3 Europe

5.3.1 Europe Therapeutic Radioisotopes Market Size (2016-2021)

5.3.2 Therapeutic Radioisotopes Key Players in Europe (2016-2021)

5.3.3 Europe Therapeutic Radioisotopes Market Size by Type (2016-2021)

5.3.4 Europe Therapeutic Radioisotopes Market Size by Application (2016-2021)

5.4 South Asia

5.4.1 South Asia Therapeutic Radioisotopes Market Size (2016-2021)

5.4.2 Therapeutic Radioisotopes Key Players in South Asia (2016-2021)

5.4.3 South Asia Therapeutic Radioisotopes Market Size by Type (2016-2021)

5.4.4 South Asia Therapeutic Radioisotopes Market Size by Application (2016-2021)

5.5 Southeast Asia

5.5.1 Southeast Asia Therapeutic Radioisotopes Market Size (2016-2021)

5.5.2 Therapeutic Radioisotopes Key Players in Southeast Asia (2016-2021)

5.5.3 Southeast Asia Therapeutic Radioisotopes Market Size by Type (2016-2021)

5.5.4 Southeast Asia Therapeutic Radioisotopes Market Size by Application (2016-2021)

5.6 Middle East

5.6.1 Middle East Therapeutic Radioisotopes Market Size (2016-2021)

5.6.2 Therapeutic Radioisotopes Key Players in Middle East (2016-2021)

5.6.3 Middle East Therapeutic Radioisotopes Market Size by Type (2016-2021)

5.6.4 Middle East Therapeutic Radioisotopes Market Size by Application (2016-2021)

5.7 Africa

5.7.1 Africa Therapeutic Radioisotopes Market Size (2016-2021)

5.7.2 Therapeutic Radioisotopes Key Players in Africa (2016-2021)

5.7.3 Africa Therapeutic Radioisotopes Market Size by Type (2016-2021)

5.7.4 Africa Therapeutic Radioisotopes Market Size by Application (2016-2021)

5.8 Oceania

5.8.1 Oceania Therapeutic Radioisotopes Market Size (2016-2021)

5.8.2 Therapeutic Radioisotopes Key Players in Oceania (2016-2021)

5.8.3 Oceania Therapeutic Radioisotopes Market Size by Type (2016-2021)

5.8.4 Oceania Therapeutic Radioisotopes Market Size by Application (2016-2021)

5.9 South America

5.9.1 South America Therapeutic Radioisotopes Market Size (2016-2021)

5.9.2 Therapeutic Radioisotopes Key Players in South America (2016-2021)

5.9.3 South America Therapeutic Radioisotopes Market Size by Type (2016-2021)

5.9.4 South America Therapeutic Radioisotopes Market Size by Application (2016-2021)

5.10 Rest of the World

5.10.1 Rest of the World Therapeutic Radioisotopes Market Size (2016-2021)

5.10.2 Therapeutic Radioisotopes Key Players in Rest of the World (2016-2021)

5.10.3 Rest of the World Therapeutic Radioisotopes Market Size by Type (2016-2021)

5.10.4 Rest of the World Therapeutic Radioisotopes Market Size by Application (2016-2021)

6 Global Therapeutic Radioisotopes Consumption by Region (2016-2021)

6.1 North America

6.1.1 North America Therapeutic Radioisotopes Consumption by Countries

6.1.2 United States

6.1.3 Canada

6.1.4 Mexico

6.2 East Asia

6.2.1 East Asia Therapeutic Radioisotopes Consumption by Countries

6.2.2 China

6.2.3 Japan

6.2.4 South Korea

6.3 Europe

6.3.1 Europe Therapeutic Radioisotopes Consumption by Countries

6.3.2 Germany

6.3.3 United Kingdom

6.3.4 France

6.3.5 Italy

6.3.6 Russia

6.3.7 Spain

6.3.8 Netherlands

6.3.9 Switzerland

6.3.10 Poland

6.4 South Asia

6.4.1 South Asia Therapeutic Radioisotopes Consumption by Countries

6.4.2 India

6.5 Southeast Asia

6.5.1 Southeast Asia Therapeutic Radioisotopes Consumption by Countries

6.5.2 Indonesia

6.5.3 Thailand

6.5.4 Singapore

6.5.5 Malaysia

6.5.6 Philippines

6.6 Middle East

6.6.1 Middle East Therapeutic Radioisotopes Consumption by Countries

6.6.2 Turkey

6.6.3 Saudi Arabia

6.6.4 Iran

6.6.5 United Arab Emirates

6.7 Africa

6.7.1 Africa Therapeutic Radioisotopes Consumption by Countries

6.7.2 Nigeria

6.7.3 South Africa

6.8 Oceania

6.8.1 Oceania Therapeutic Radioisotopes Consumption by Countries

6.8.2 Australia

6.9 South America

6.9.1 South America Therapeutic Radioisotopes Consumption by Countries

6.9.2 Brazil

6.9.3 Argentina

6.10 Rest of the World

6.10.1 Rest of the World Therapeutic Radioisotopes Consumption by Countries

7 Global Therapeutic Radioisotopes Production Forecast by Regions (2022-2027)

7.1 Global Forecasted Production of Therapeutic Radioisotopes (2022-2027)

7.2 Global Forecasted Revenue of Therapeutic Radioisotopes (2022-2027)

7.3 Global Forecasted Price of Therapeutic Radioisotopes (2022-2027)

7.4 Global Forecasted Production of Therapeutic Radioisotopes by Region (2022-2027)

7.4.1 North America Therapeutic Radioisotopes Production, Revenue Forecast (2022-2027)

7.4.2 East Asia Therapeutic Radioisotopes Production, Revenue Forecast (2022-2027)

7.4.3 Europe Therapeutic Radioisotopes Production, Revenue Forecast (2022-2027)

7.4.4 South Asia Therapeutic Radioisotopes Production, Revenue Forecast (2022-2027)

7.4.5 Southeast Asia Therapeutic Radioisotopes Production, Revenue Forecast (2022-2027)

7.4.6 Middle East Therapeutic Radioisotopes Production, Revenue Forecast (2022-2027)

7.4.7 Africa Therapeutic Radioisotopes Production, Revenue Forecast (2022-2027)

7.4.8 Oceania Therapeutic Radioisotopes Production, Revenue Forecast (2022-2027)

7.4.9 South America Therapeutic Radioisotopes Production, Revenue Forecast (2022-2027)

7.4.10 Rest of the World Therapeutic Radioisotopes Production, Revenue Forecast (2022-2027)

7.5 Forecast by Type and by Application (2022-2027)

7.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)

7.5.2 Global Forecasted Consumption of Therapeutic Radioisotopes by Application (2022-2027)

8 Global Therapeutic Radioisotopes Consumption Forecast by Regions (2022-2027)

8.1 North America Forecasted Consumption of Therapeutic Radioisotopes by Country

8.2 East Asia Market Forecasted Consumption of Therapeutic Radioisotopes by Country

8.3 Europe Market Forecasted Consumption of Therapeutic Radioisotopes by Countriy

8.4 South Asia Forecasted Consumption of Therapeutic Radioisotopes by Country

8.5 Southeast Asia Forecasted Consumption of Therapeutic Radioisotopes by Country

8.6 Middle East Forecasted Consumption of Therapeutic Radioisotopes by Country

8.7 Africa Forecasted Consumption of Therapeutic Radioisotopes by Country

8.8 Oceania Forecasted Consumption of Therapeutic Radioisotopes by Country

8.9 South America Forecasted Consumption of Therapeutic Radioisotopes by Country

8.10 Rest of the world Forecasted Consumption of Therapeutic Radioisotopes by Country

9 Global Therapeutic Radioisotopes Sales by Type (2016-2027)

9.1 Global Therapeutic Radioisotopes Historic Market Size by Type (2016-2021)

9.2 Global Therapeutic Radioisotopes Forecasted Market Size by Type (2022-2027)

10 Global Therapeutic Radioisotopes Consumption by Application (2016-2027)

10.1 Global Therapeutic Radioisotopes Historic Market Size by Application (2016-2021)

10.2 Global Therapeutic Radioisotopes Forecasted Market Size by Application (2022-2027)

11 Global Therapeutic Radioisotopes Manufacturing Cost Analysis

11.1 Therapeutic Radioisotopes Key Raw Materials Analysis

11.1.1 Key Raw Materials

11.2 Proportion of Manufacturing Cost Structure

11.3 Manufacturing Process Analysis of Therapeutic Radioisotopes

12 Global Therapeutic Radioisotopes Marketing Channel, Distributors, Customers and Supply Chain

12.1 Marketing Channel

12.2 Therapeutic Radioisotopes Distributors List

12.3 Therapeutic Radioisotopes Customers

12.4 Therapeutic Radioisotopes Supply Chain Analysis

13 Analyst's Viewpoints/Conclusions

14 Disclaimer

Table 1. Research Programs/Design for This Report

Table 2. Key Data Information from Secondary Sources

Table 3. Key Executives Interviewed

Table 4. Key Data Information from Primary Sources

Table 5. Key Players Covered: Ranking by Therapeutic Radioisotopes Revenue (US$ Million) 2016-2021

Table 6. Global Therapeutic Radioisotopes Market Size by Type (US$ Million): 2022-2027

Table 7. Radium-223 Features

Table 8. Lutetium-177 Features

Table 9. Iodine-131 Features

Table 10. Other Features

Table 16. Global Therapeutic Radioisotopes Market Size by Application (US$ Million): 2022-2027

Table 17. Thyroid Case Studies

Table 18. Bone Metastasis Case Studies

Table 19. Lymphoma Case Studies

Table 20. Other Case Studies

Table 26. Overview of the World Economic Outlook Projections

Table 27. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)

Table 28. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 29. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 30. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 31. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 32. Commodity Prices-Metals Price Indices

Table 33. Commodity Prices- Precious Metal Price Indices

Table 34. Commodity Prices- Agricultural Raw Material Price Indices

Table 35. Commodity Prices- Food and Beverage Price Indices

Table 36. Commodity Prices- Fertilizer Price Indices

Table 37. Commodity Prices- Energy Price Indices

Table 38. G20+: Economic Policy Responses to COVID-19

Table 39. Covid-19 Impact: Global Major Government Policy

Table 40. Therapeutic Radioisotopes Report Years Considered

Table 41. Market Top Trends

Table 42. Key Drivers: Impact Analysis

Table 43. Key Challenges

Table 44. Porter's Five Forces Analysis

Table 45. Therapeutic Radioisotopes Market Growth Strategy

Table 46. Therapeutic Radioisotopes SWOT Analysis

Table 47. Bayer Therapeutic Radioisotopes Product Specification

Table 48. Bayer Therapeutic Radioisotopes Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 49. Novartis Therapeutic Radioisotopes Product Specification

Table 50. Novartis Therapeutic Radioisotopes Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 51. China Isotope & Radiation Therapeutic Radioisotopes Product Specification

Table 52. China Isotope & Radiation Therapeutic Radioisotopes Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 53. Dongcheng Therapeutic Radioisotopes Product Specification

Table 54. Table Dongcheng Therapeutic Radioisotopes Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 55. Q BioMed Therapeutic Radioisotopes Product Specification

Table 56. Q BioMed Therapeutic Radioisotopes Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 57. Curium Pharmaceuticals Therapeutic Radioisotopes Product Specification

Table 58. Curium Pharmaceuticals Therapeutic Radioisotopes Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 59. Jubilant DraxImage Therapeutic Radioisotopes Product Specification

Table 60. Jubilant DraxImage Therapeutic Radioisotopes Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 61. Lantheus Therapeutic Radioisotopes Product Specification

Table 62. Lantheus Therapeutic Radioisotopes Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 63. Spectrum Pharmaceuticals Therapeutic Radioisotopes Product Specification

Table 64. Spectrum Pharmaceuticals Therapeutic Radioisotopes Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 65. Progenics Pharmaceuticals Therapeutic Radioisotopes Product Specification

Table 66. Progenics Pharmaceuticals Therapeutic Radioisotopes Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 67. International Isotopes Therapeutic Radioisotopes Product Specification

Table 68. International Isotopes Therapeutic Radioisotopes Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 147. Global Therapeutic Radioisotopes Production Capacity by Market Players

Table 148. Global Therapeutic Radioisotopes Production by Market Players (2016-2021)

Table 149. Global Therapeutic Radioisotopes Production Market Share by Market Players (2016-2021)

Table 150. Global Therapeutic Radioisotopes Revenue by Market Players (2016-2021)

Table 151. Global Therapeutic Radioisotopes Revenue Share by Market Players (2016-2021)

Table 152. Global Market Therapeutic Radioisotopes Average Price of Key Market Players (2016-2021)

Table 153. North America Key Players Therapeutic Radioisotopes Revenue (2016-2021) (US$ Million)

Table 154. North America Key Players Therapeutic Radioisotopes Market Share (2016-2021)

Table 155. North America Therapeutic Radioisotopes Market Size by Type (2016-2021) (US$ Million)

Table 156. North America Therapeutic Radioisotopes Market Share by Type (2016-2021)

Table 157. North America Therapeutic Radioisotopes Market Size by Application (2016-2021) (US$ Million)

Table 158. North America Therapeutic Radioisotopes Market Share by Application (2016-2021)

Table 159. East Asia Therapeutic Radioisotopes Market Size YoY Growth (2016-2021) (US$ Million)

Table 160. East Asia Key Players Therapeutic Radioisotopes Revenue (2016-2021) (US$ Million)

Table 161. East Asia Key Players Therapeutic Radioisotopes Market Share (2016-2021)

Table 162. East Asia Therapeutic Radioisotopes Market Size by Type (2016-2021) (US$ Million)

Table 163. East Asia Therapeutic Radioisotopes Market Share by Type (2016-2021)

Table 164. East Asia Therapeutic Radioisotopes Market Size by Application (2016-2021) (US$ Million)

Table 165. East Asia Therapeutic Radioisotopes Market Share by Application (2016-2021)

Table 166. Europe Therapeutic Radioisotopes Market Size YoY Growth (2016-2021) (US$ Million)

Table 167. Europe Key Players Therapeutic Radioisotopes Revenue (2016-2021) (US$ Million)

Table 168. Europe Key Players Therapeutic Radioisotopes Market Share (2016-2021)

Table 169. Europe Therapeutic Radioisotopes Market Size by Type (2016-2021) (US$ Million)

Table 170. Europe Therapeutic Radioisotopes Market Share by Type (2016-2021)

Table 171. Europe Therapeutic Radioisotopes Market Size by Application (2016-2021) (US$ Million)

Table 172. Europe Therapeutic Radioisotopes Market Share by Application (2016-2021)

Table 173. South Asia Therapeutic Radioisotopes Market Size YoY Growth (2016-2021) (US$ Million)

Table 174. South Asia Key Players Therapeutic Radioisotopes Revenue (2016-2021) (US$ Million)

Table 175. South Asia Key Players Therapeutic Radioisotopes Market Share (2016-2021)

Table 176. South Asia Therapeutic Radioisotopes Market Size by Type (2016-2021) (US$ Million)

Table 177. South Asia Therapeutic Radioisotopes Market Share by Type (2016-2021)

Table 178. South Asia Therapeutic Radioisotopes Market Size by Application (2016-2021) (US$ Million)

Table 179. South Asia Therapeutic Radioisotopes Market Share by Application (2016-2021)

Table 180. Southeast Asia Therapeutic Radioisotopes Market Size YoY Growth (2016-2021) (US$ Million)

Table 181. Southeast Asia Key Players Therapeutic Radioisotopes Revenue (2016-2021) (US$ Million)

Table 182. Southeast Asia Key Players Therapeutic Radioisotopes Market Share (2016-2021)

Table 183. Southeast Asia Therapeutic Radioisotopes Market Size by Type (2016-2021) (US$ Million)

Table 184. Southeast Asia Therapeutic Radioisotopes Market Share by Type (2016-2021)

Table 185. Southeast Asia Therapeutic Radioisotopes Market Size by Application (2016-2021) (US$ Million)

Table 186. Southeast Asia Therapeutic Radioisotopes Market Share by Application (2016-2021)

Table 187. Middle East Therapeutic Radioisotopes Market Size YoY Growth (2016-2021) (US$ Million)

Table 188. Middle East Key Players Therapeutic Radioisotopes Revenue (2016-2021) (US$ Million)

Table 189. Middle East Key Players Therapeutic Radioisotopes Market Share (2016-2021)

Table 190. Middle East Therapeutic Radioisotopes Market Size by Type (2016-2021) (US$ Million)

Table 191. Middle East Therapeutic Radioisotopes Market Share by Type (2016-2021)

Table 192. Middle East Therapeutic Radioisotopes Market Size by Application (2016-2021) (US$ Million)

Table 193. Middle East Therapeutic Radioisotopes Market Share by Application (2016-2021)

Table 194. Africa Therapeutic Radioisotopes Market Size YoY Growth (2016-2021) (US$ Million)

Table 195. Africa Key Players Therapeutic Radioisotopes Revenue (2016-2021) (US$ Million)

Table 196. Africa Key Players Therapeutic Radioisotopes Market Share (2016-2021)

Table 197. Africa Therapeutic Radioisotopes Market Size by Type (2016-2021) (US$ Million)

Table 198. Africa Therapeutic Radioisotopes Market Share by Type (2016-2021)

Table 199. Africa Therapeutic Radioisotopes Market Size by Application (2016-2021) (US$ Million)

Table 200. Africa Therapeutic Radioisotopes Market Share by Application (2016-2021)

Table 201. Oceania Therapeutic Radioisotopes Market Size YoY Growth (2016-2021) (US$ Million)

Table 202. Oceania Key Players Therapeutic Radioisotopes Revenue (2016-2021) (US$ Million)

Table 203. Oceania Key Players Therapeutic Radioisotopes Market Share (2016-2021)

Table 204. Oceania Therapeutic Radioisotopes Market Size by Type (2016-2021) (US$ Million)

Table 205. Oceania Therapeutic Radioisotopes Market Share by Type (2016-2021)

Table 206. Oceania Therapeutic Radioisotopes Market Size by Application (2016-2021) (US$ Million)

Table 207. Oceania Therapeutic Radioisotopes Market Share by Application (2016-2021)

Table 208. South America Therapeutic Radioisotopes Market Size YoY Growth (2016-2021) (US$ Million)

Table 209. South America Key Players Therapeutic Radioisotopes Revenue (2016-2021) (US$ Million)

Table 210. South America Key Players Therapeutic Radioisotopes Market Share (2016-2021)

Table 211. South America Therapeutic Radioisotopes Market Size by Type (2016-2021) (US$ Million)

Table 212. South America Therapeutic Radioisotopes Market Share by Type (2016-2021)

Table 213. South America Therapeutic Radioisotopes Market Size by Application (2016-2021) (US$ Million)

Table 214. South America Therapeutic Radioisotopes Market Share by Application (2016-2021)

Table 215. Rest of the World Therapeutic Radioisotopes Market Size YoY Growth (2016-2021) (US$ Million)

Table 216. Rest of the World Key Players Therapeutic Radioisotopes Revenue (2016-2021) (US$ Million)

Table 217. Rest of the World Key Players Therapeutic Radioisotopes Market Share (2016-2021)

Table 218. Rest of the World Therapeutic Radioisotopes Market Size by Type (2016-2021) (US$ Million)

Table 219. Rest of the World Therapeutic Radioisotopes Market Share by Type (2016-2021)

Table 220. Rest of the World Therapeutic Radioisotopes Market Size by Application (2016-2021) (US$ Million)

Table 221. Rest of the World Therapeutic Radioisotopes Market Share by Application (2016-2021)

Table 222. North America Therapeutic Radioisotopes Consumption by Countries (2016-2021)

Table 223. East Asia Therapeutic Radioisotopes Consumption by Countries (2016-2021)

Table 224. Europe Therapeutic Radioisotopes Consumption by Region (2016-2021)

Table 225. South Asia Therapeutic Radioisotopes Consumption by Countries (2016-2021)

Table 226. Southeast Asia Therapeutic Radioisotopes Consumption by Countries (2016-2021)

Table 227. Middle East Therapeutic Radioisotopes Consumption by Countries (2016-2021)

Table 228. Africa Therapeutic Radioisotopes Consumption by Countries (2016-2021)

Table 229. Oceania Therapeutic Radioisotopes Consumption by Countries (2016-2021)

Table 230. South America Therapeutic Radioisotopes Consumption by Countries (2016-2021)

Table 231. Rest of the World Therapeutic Radioisotopes Consumption by Countries (2016-2021)

Table 232. Global Therapeutic Radioisotopes Production Forecast by Region (2022-2027)

Table 233. Global Therapeutic Radioisotopes Sales Volume Forecast by Type (2022-2027)

Table 234. Global Therapeutic Radioisotopes Sales Volume Market Share Forecast by Type (2022-2027)

Table 235. Global Therapeutic Radioisotopes Sales Revenue Forecast by Type (2022-2027)

Table 236. Global Therapeutic Radioisotopes Sales Revenue Market Share Forecast by Type (2022-2027)

Table 237. Global Therapeutic Radioisotopes Sales Price Forecast by Type (2022-2027)

Table 238. Global Therapeutic Radioisotopes Consumption Volume Forecast by Application (2022-2027)

Table 239. Global Therapeutic Radioisotopes Consumption Value Forecast by Application (2022-2027)

Table 240. North America Therapeutic Radioisotopes Consumption Forecast 2022-2027 by Country

Table 241. East Asia Therapeutic Radioisotopes Consumption Forecast 2022-2027 by Country

Table 242. Europe Therapeutic Radioisotopes Consumption Forecast 2022-2027 by Country

Table 243. South Asia Therapeutic Radioisotopes Consumption Forecast 2022-2027 by Country

Table 244. Southeast Asia Therapeutic Radioisotopes Consumption Forecast 2022-2027 by Country

Table 245. Middle East Therapeutic Radioisotopes Consumption Forecast 2022-2027 by Country

Table 246. Africa Therapeutic Radioisotopes Consumption Forecast 2022-2027 by Country

Table 247. Oceania Therapeutic Radioisotopes Consumption Forecast 2022-2027 by Country

Table 248. South America Therapeutic Radioisotopes Consumption Forecast 2022-2027 by Country

Table 249. Rest of the world Therapeutic Radioisotopes Consumption Forecast 2022-2027 by Country

Table 250. Global Therapeutic Radioisotopes Market Size by Type (2016-2021) (US$ Million)

Table 251. Global Therapeutic Radioisotopes Revenue Market Share by Type (2016-2021)

Table 252. Global Therapeutic Radioisotopes Forecasted Market Size by Type (2022-2027) (US$ Million)

Table 253. Global Therapeutic Radioisotopes Revenue Market Share by Type (2022-2027)

Table 254. Global Therapeutic Radioisotopes Market Size by Application (2016-2021) (US$ Million)

Table 255. Global Therapeutic Radioisotopes Revenue Market Share by Application (2016-2021)

Table 256. Global Therapeutic Radioisotopes Forecasted Market Size by Application (2022-2027) (US$ Million)

Table 257. Global Therapeutic Radioisotopes Revenue Market Share by Application (2022-2027)

Table 258. Therapeutic Radioisotopes Distributors List

Table 259. Therapeutic Radioisotopes Customers List

Figure 1. Product Figure

Figure 2. Global Therapeutic Radioisotopes Market Share by Type: 2021 VS 2027

Figure 3. Global Therapeutic Radioisotopes Market Share by Application: 2021 VS 2027

Figure 4. North America Therapeutic Radioisotopes Market Size YoY Growth (2016-2021) (US$ Million)

Figure 5. North America Therapeutic Radioisotopes Consumption and Growth Rate (2016-2021)

Figure 6. North America Therapeutic Radioisotopes Consumption Market Share by Countries in 2021

Figure 7. United States Therapeutic Radioisotopes Consumption and Growth Rate (2016-2021)

Figure 8. Canada Therapeutic Radioisotopes Consumption and Growth Rate (2016-2021)

Figure 9. Mexico Therapeutic Radioisotopes Consumption and Growth Rate (2016-2021)

Figure 10. East Asia Therapeutic Radioisotopes Consumption and Growth Rate (2016-2021)

Figure 11. East Asia Therapeutic Radioisotopes Consumption Market Share by Countries in 2021

Figure 12. China Therapeutic Radioisotopes Consumption and Growth Rate (2016-2021)

Figure 13. Japan Therapeutic Radioisotopes Consumption and Growth Rate (2016-2021)

Figure 14. South Korea Therapeutic Radioisotopes Consumption and Growth Rate (2016-2021)

Figure 15. Europe Therapeutic Radioisotopes Consumption and Growth Rate

Figure 16. Europe Therapeutic Radioisotopes Consumption Market Share by Region in 2021

Figure 17. Germany Therapeutic Radioisotopes Consumption and Growth Rate (2016-2021)

Figure 18. United Kingdom Therapeutic Radioisotopes Consumption and Growth Rate (2016-2021)

Figure 19. France Therapeutic Radioisotopes Consumption and Growth Rate (2016-2021)

Figure 20. Italy Therapeutic Radioisotopes Consumption and Growth Rate (2016-2021)

Figure 21. Russia Therapeutic Radioisotopes Consumption and Growth Rate (2016-2021)

Figure 22. Spain Therapeutic Radioisotopes Consumption and Growth Rate (2016-2021)

Figure 23. Netherlands Therapeutic Radioisotopes Consumption and Growth Rate (2016-2021)

Figure 24. Switzerland Therapeutic Radioisotopes Consumption and Growth Rate (2016-2021)

Figure 25. Poland Therapeutic Radioisotopes Consumption and Growth Rate (2016-2021)

Figure 26. South Asia Therapeutic Radioisotopes Consumption and Growth Rate

Figure 27. South Asia Therapeutic Radioisotopes Consumption Market Share by Countries in 2021

Figure 28. India Therapeutic Radioisotopes Consumption and Growth Rate (2016-2021)

Figure 29. Southeast Asia Therapeutic Radioisotopes Consumption and Growth Rate

Figure 30. Southeast Asia Therapeutic Radioisotopes Consumption Market Share by Countries in 2021

Figure 31. Indonesia Therapeutic Radioisotopes Consumption and Growth Rate (2016-2021)

Figure 32. Thailand Therapeutic Radioisotopes Consumption and Growth Rate (2016-2021)

Figure 33. Singapore Therapeutic Radioisotopes Consumption and Growth Rate (2016-2021)

Figure 34. Malaysia Therapeutic Radioisotopes Consumption and Growth Rate (2016-2021)

Figure 35. Philippines Therapeutic Radioisotopes Consumption and Growth Rate (2016-2021)

Figure 36. Middle East Therapeutic Radioisotopes Consumption and Growth Rate

Figure 37. Middle East Therapeutic Radioisotopes Consumption Market Share by Countries in 2021

Figure 38. Turkey Therapeutic Radioisotopes Consumption and Growth Rate (2016-2021)

Figure 39. Saudi Arabia Therapeutic Radioisotopes Consumption and Growth Rate (2016-2021)

Figure 40. Iran Therapeutic Radioisotopes Consumption and Growth Rate (2016-2021)

Figure 41. United Arab Emirates Therapeutic Radioisotopes Consumption and Growth Rate (2016-2021)

Figure 42. Africa Therapeutic Radioisotopes Consumption and Growth Rate

Figure 43. Africa Therapeutic Radioisotopes Consumption Market Share by Countries in 2021

Figure 44. Nigeria Therapeutic Radioisotopes Consumption and Growth Rate (2016-2021)

Figure 45. South Africa Therapeutic Radioisotopes Consumption and Growth Rate (2016-2021)

Figure 46. Oceania Therapeutic Radioisotopes Consumption and Growth Rate

Figure 47. Oceania Therapeutic Radioisotopes Consumption Market Share by Countries in 2021

Figure 48. Australia Therapeutic Radioisotopes Consumption and Growth Rate (2016-2021)

Figure 49. South America Therapeutic Radioisotopes Consumption and Growth Rate

Figure 50. South America Therapeutic Radioisotopes Consumption Market Share by Countries in 2021

Figure 51. Brazil Therapeutic Radioisotopes Consumption and Growth Rate (2016-2021)

Figure 52. Argentina Therapeutic Radioisotopes Consumption and Growth Rate (2016-2021)

Figure 53. Rest of the World Therapeutic Radioisotopes Consumption and Growth Rate

Figure 54. Rest of the World Therapeutic Radioisotopes Consumption Market Share by Countries in 2021

Figure 55. Global Therapeutic Radioisotopes Production Capacity Growth Rate Forecast (2022-2027)

Figure 56. Global Therapeutic Radioisotopes Revenue Growth Rate Forecast (2022-2027)

Figure 57. Global Therapeutic Radioisotopes Price and Trend Forecast (2022-2027)

Figure 58. North America Therapeutic Radioisotopes Production Growth Rate Forecast (2022-2027)

Figure 59. North America Therapeutic Radioisotopes Revenue Growth Rate Forecast (2022-2027)

Figure 60. East Asia Therapeutic Radioisotopes Production Growth Rate Forecast (2022-2027)

Figure 61. East Asia Therapeutic Radioisotopes Revenue Growth Rate Forecast (2022-2027)

Figure 62. Europe Therapeutic Radioisotopes Production Growth Rate Forecast (2022-2027)

Figure 63. Europe Therapeutic Radioisotopes Revenue Growth Rate Forecast (2022-2027)

Figure 64. South Asia Therapeutic Radioisotopes Production Growth Rate Forecast (2022-2027)

Figure 65. South Asia Therapeutic Radioisotopes Revenue Growth Rate Forecast (2022-2027)

Figure 66. Southeast Asia Therapeutic Radioisotopes Production Growth Rate Forecast (2022-2027)

Figure 67. Southeast Asia Therapeutic Radioisotopes Revenue Growth Rate Forecast (2022-2027)

Figure 68. Middle East Therapeutic Radioisotopes Production Growth Rate Forecast (2022-2027)

Figure 69. Middle East Therapeutic Radioisotopes Revenue Growth Rate Forecast (2022-2027)

Figure 70. Africa Therapeutic Radioisotopes Production Growth Rate Forecast (2022-2027)

Figure 71. Africa Therapeutic Radioisotopes Revenue Growth Rate Forecast (2022-2027)

Figure 72. Oceania Therapeutic Radioisotopes Production Growth Rate Forecast (2022-2027)

Figure 73. Oceania Therapeutic Radioisotopes Revenue Growth Rate Forecast (2022-2027)

Figure 74. South America Therapeutic Radioisotopes Production Growth Rate Forecast (2022-2027)

Figure 75. South America Therapeutic Radioisotopes Revenue Growth Rate Forecast (2022-2027)

Figure 76. Rest of the World Therapeutic Radioisotopes Production Growth Rate Forecast (2022-2027)

Figure 77. Rest of the World Therapeutic Radioisotopes Revenue Growth Rate Forecast (2022-2027)

Figure 78. North America Therapeutic Radioisotopes Consumption Forecast 2022-2027

Figure 79. East Asia Therapeutic Radioisotopes Consumption Forecast 2022-2027

Figure 80. Europe Therapeutic Radioisotopes Consumption Forecast 2022-2027

Figure 81. South Asia Therapeutic Radioisotopes Consumption Forecast 2022-2027

Figure 82. Southeast Asia Therapeutic Radioisotopes Consumption Forecast 2022-2027

Figure 83. Middle East Therapeutic Radioisotopes Consumption Forecast 2022-2027

Figure 84. Africa Therapeutic Radioisotopes Consumption Forecast 2022-2027

Figure 85. Oceania Therapeutic Radioisotopes Consumption Forecast 2022-2027

Figure 86. South America Therapeutic Radioisotopes Consumption Forecast 2022-2027

Figure 87. Rest of the world Therapeutic Radioisotopes Consumption Forecast 2022-2027

Figure 88. Manufacturing Cost Structure of Therapeutic Radioisotopes

Figure 89. Manufacturing Process Analysis of Therapeutic Radioisotopes

Figure 90. Channels of Distribution

Figure 91. Distributors Profiles

Figure 92. Therapeutic Radioisotopes Supply Chain Analysis

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390